ストックスクリーナーアプリを入手
26.18
3.36%
0.85
アフターアワーズ：
25.00
-1.18
-4.51%
Staar Surgical Co (STAA) 最新ニュース
Why STAAR Surgical (STAA) Is Up 8.1% After Returning To Profit Under New CEO Warren Foust – And What's Next - simplywall.st
STAA Q2 Deep Dive: China Demand and Product Expansion Drive Revenue Growth Amid Market Caution - Yahoo Finance
STAAR Surgical (STAA) Gives Warren Foust The CEO Role After Its Profit Reset - Yahoo Finance
Quantinno Capital Management LP Takes $1.11 Million Position in STAAR Surgical Company $STAA - MarketBeat
Staar Surgical Co (STAA) Shares Surge 3.4% -- What GF Score of 8 - GuruFocus
STAAR Surgical (STAA) reports 8.4% stake held by Madison Avenue group - Stock Titan
STAAR Surgical earnings beat by $0.02, revenue topped estimates - Investing.com Canada
STAAR Surgical (STAA) Stock Price Shrugs Off Profit Rebound As China Dominates - simplywall.st
Jefferies cuts STAAR Surgical stock price target on estimate update By Investing.com - Investing.com South Africa
STAA Maintains Rating by UBS -- Price Target Lowered to $19.00 - GuruFocus
Jefferies cuts STAAR Surgical stock price target on estimate update - Investing.com
STAA Maintained by Wedbush -- Price Target Lowered to $37.00 - GuruFocus
Piper Sandler reiterates Neutral on STAAR Surgical stock at $33 By Investing.com - Investing.com South Africa
Piper Sandler reiterates Neutral on STAAR Surgical stock at $33 - Investing.com
STAAR Surgical Company Q2 2026 Earnings Call Summary - Yahoo Finance
Staar Surgical Co (STAA) (Q2 2026) Earnings Call Highlights: Record Revenue Surge and Strategic ... - Yahoo Finance
STAA SWOT Analysis: Strong Financial Recovery Revealed in 10-Q F - GuruFocus
STAA Looks 19.9% Undervalued on GF Value™ - GuruFocus
Why STAAR Surgical (STAA) Is Getting Fresh Attention Now - simplywall.st
Earnings call transcript: STAAR Surgical tops revenue views in Q2 2026 - Investing.com Nigeria
STAAR Surgical Q2 EPS $0.16 beats $0.15 estimate; sales up 111% - scanx.trade
STAAR Surgical (NASDAQ:STAA) Releases Quarterly Earnings Results, Misses Estimates By $0.06 EPS - MarketBeat
Is Staar Surgical Co (STAA) Undervalued After Q2 Earnings? EPS a - GuruFocus
STAAR Surgical Posts Strong Q2 2026 Earnings, Net Income Surges to $8.1 Million - Kalkine Media
STAAR Surgical Company (STAA) Q2 FY2026 earnings call transcript - Yahoo Finance
STAAR Surgical Q2 2026 Earnings: China Rebound Restores Profitability - TradingKey
Earnings Flash (STAA) STAAR Surgical Posts Q2 EPS $0.16, vs. FactSet Est of $0.14 - marketscreener.com
Staar Surgical: Q2 Earnings Snapshot - marketscreener.com
STAAR Surgical (STAA) more than doubles Q2 sales and returns to profit - Stock Titan
STAAR Surgical Reports Second Quarter 2026 Results - Business Wire
STAAR Surgical faces earnings test amid China growth, CEO transition - Investing.com
STAA|STAAR Surgical Co|Price:26.180|Chg%:+0.850 - TradingKey
Defender Capital LLC. Has $12.37 Million Position in STAAR Surgical Company $STAA - MarketBeat
Masimo, Staar Name New Leaders - Orange County Business Journal
Renaissance Technologies LLC Acquires 97,400 Shares of STAAR Surgical Company $STAA - MarketBeat
How Investors Are Reacting To STAAR Surgical (STAA) Formalizing Warren Foust’s CEO Role And Leadership Structure - simplywall.st
Janus Henderson Group PLC Sells 82,283 Shares of STAAR Surgical Company $STAA - MarketBeat
STAAR Surgical Company $STAA Holdings Raised by Dimensional Fund Advisors LP - MarketBeat
Staar Surgical Names Warren Foust Permanent CEO, CFO Promoted - The Globe and Mail
STAA Stock On Track For Its Fourth Straight Session Of Gains – This Analyst Would Rather Be Early Than Late On Staar’s Growth Story - Stocktwits
STAAR Surgical Appoints Warren Foust as Permanent CEO with Detailed Compensation Plan - Kalkine Media
Form 8K STAAR Surgical Company For: 6 August By Investing.com - Investing.com Canada
STAAR Surgical (NASDAQ: STAA) names Warren Foust chief executive - Stock Titan
STAAR Surgical appoints Warren Foust as permanent CEO - MedTech Dive
Staar Appoints Warren Foust as Permanent CEO - Orange County Business Journal
STAAR Surgical Names Warren Foust as Permanent CEO - Medical Product Outsourcing
Staar Surgical Appoints Warren Foust as President and CEO - Eyewire+
Warren Foust Named President and CEO of STAAR Surgical, Deborah Andrews Transitions to Executive Vice President and CFO Roles - VisionMonday.com
STAAR Surgical names Warren Foust CEO, Andrews to EVP and CFO - Investing.com
Staar Surgical picks current COO, former J&J exec as new CEO - MassDevice
STAAR Surgical Appoints Warren Foust as President and Chief Executive Officer - marketscreener.com
STAAR Surgical Company Appoints Warren Foust as Member of Its Board of Directors and Deborah Andrews as Executive Vice President, Effective August 4, 2026 - marketscreener.com
STAAR Surgical to discuss vision correction business Aug. 12 - Stock Titan
STAA Reiterated by Wedbush -- Price Target Maintained at $40 - GuruFocus
STAAR Surgical Company (STAA) Stock Forecasts - Yahoo Finance
STAAR Surgical Co (STAA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
2.90%
1.18%
大文字化:
|
ボリューム (24 時間):